December 2022 Anthem Provider News - Missouri

Contents

AdministrativeCommercialDecember 1, 2022

CAA: Timely updates help keep our provider directories current

AdministrativeCommercialDecember 1, 2022

Attention lab providers: COVID-19 update regarding reimbursement

AdministrativeCommercialDecember 1, 2022

Member assessment of PCP after-hours messaging in 2022

AdministrativeCommercialDecember 1, 2022

Important information about utilization management

AdministrativeCommercialDecember 1, 2022

Members’ rights and responsibilities

AdministrativeCommercialDecember 1, 2022

Coordination of care

AdministrativeCommercialDecember 1, 2022

Case management program

AdministrativeCommercialDecember 1, 2022

IngenioRx will become CarelonRx on January 1, 2023

Medical Policy & Clinical GuidelinesCommercialDecember 1, 2022

AIM Specialty Health Cardiology Clinical Appropriateness Guidelines CPT Code List update

Medical Policy & Clinical GuidelinesCommercialDecember 1, 2022

AIM Specialty Health Genetic Testing Clinical Appropriateness Guidelines CPT Code List update

Medical Policy & Clinical GuidelinesCommercialDecember 1, 2022

Medical Policies and Clinical Guidelines updates - December 2022

Reimbursement PoliciesCommercialDecember 1, 2022

Reimbursement policy update: Multiple Surgery - Facility

Reimbursement PoliciesCommercialDecember 1, 2022

Reimbursement policy update: Bundled Services and Supplies - Professional

PharmacyCommercialDecember 1, 2022

Pharmacy information available on the provider website

PharmacyCommercialDecember 1, 2022

Specialty pharmacy updates - December 2022

State & FederalMedicare AdvantageDecember 1, 2022

Keep up with Medicare News - December 2022

State & FederalMedicare AdvantageDecember 1, 2022

2023 Medicare Advantage service area and benefit updates

State & FederalMedicare AdvantageDecember 1, 2022

Personal home helper benefit ending

AdministrativeCommercialDecember 1, 2022

CAA: Timely updates help keep our provider directories current

Submitting your updates in a timely manner helps ensure we have the most current online provider directory information available to members. We ask that you review your information regularly and let us know as soon as possible if any of your information we show in our online directory has changed.

 

If updates are needed, you can use our online Provider Maintenance Form. Once you submit the form, you will receive an email acknowledging receipt of your request. Visit the Provider Maintenance Form webpage for complete instructions.

 

Online update options include:

  • Add/change an address location.
  • Name change.
  • Tax ID changes.
  • Provider leaving a group or a single location.
  • Phone/fax number changes.
  • Closing a practice location.

 

Note that some updates may require additional documentation.

 

The Consolidated Appropriations Act (CAA), effective since January 1, 2022, contains a provision that requires online provider directory information be reviewed and updated (if needed) at least every 90 days. Help us keep our online provider directories current.


MULTI-BCBS-CM-012527-22-CPN12437

AdministrativeCommercialDecember 1, 2022

Attention lab providers: COVID-19 update regarding reimbursement

Material Adverse Change (MAC)

 

Reimbursement changes to COVID-19 laboratory services codes for Commercial and Medicare Advantage programs from Anthem Blue Cross and Blue Shield (Anthem) in Missouri.

 

Beginning with dates of service on or after January 12, 2023, or the end of the public health emergency (PHE), whichever is the latter, reimbursement for COVID-19 laboratory services codes will be reduced for providers contracted as independent laboratory (ancillary) providers and participating in an Anthem Independent Laboratory Provider network.

 

New COVID-19 laboratory service codes were implemented and reimbursed at rates to meet the needs of providers during the PHE. Reimbursement will be revised to Anthem’s standard reimbursement methodology for independent laboratory providers for the following codes:

 

U0001

86328

87426

87811

0226U

U0002

86408

87428

0202U

0240U

U0003

86409

87635

0223U

0241U

U0004

86413

87636

0224U

 

U0005

86769

87637

0225U

 

 

The revised standard fee schedule for the COVID-19 laboratory services codes outlined above can be viewed on www.availity.com* beginning January 12, 2023.

 

If you have any questions regarding this notice, please contact your designated Ancillary Provider Network manager. Please incorporate this notice into your Anthem provider agreement folder.


* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield.
MOBCBS-CRCM-013047-22-CPN12350

AdministrativeCommercialDecember 1, 2022

Clinical practice and preventive health guidelines available on anthem.com

As part of our commitment to provide you with the latest clinical information and educational materials, we have adopted nationally recognized medical, behavioral health and preventive health guidelines, which are available to providers on our website. The guidelines, which are used for our quality programs, are based on reasonable, medical evidence, and are reviewed for content accuracy, current primary sources, the newest technological advances and recent medical research. 

 

All guidelines are reviewed annually, and updated as needed. The current guidelines are available on our website at anthem.com > For Providers > Select Policies, Guidelines & Manuals under Provider Resources > scroll down and select Clinical Practice Guidelines or Preventive Health Guidelines.

MULTI-BCBS-CM-012592-22

AdministrativeCommercialDecember 1, 2022

Member assessment of PCP after-hours messaging in 2022

We have provided many articles advising providers of the compliant messaging when our members call your office during an urgent situation after regular business hours.

 

The annual after-hours access studies performed by our vendor, North American Testing Organization* based in California, assesses adequate phone messaging for our members with perceived emergency or urgent situations after office hours. Unfortunately, most of the Anthem Blue Cross and Blue Shield (Anthem) plans assessed still fall short of the expectation of having a live person or a directive in place for after-hours calls.

 

Members are experiencing this lack of ability to reach instructions and have voiced their opinions in the member experience surveys fielded annually for Commercial and Marketplace Exchange. An average of 16% of members have a need to contact their provider’s office after regular hours for urgent care. They are recalling, in the last 12 months, if they were able to reach the office via an appropriate message, a transfer directly to their doctor or service for instructions, or advice.

 

This chart represents the office level accessibility when contacted by the survey vendor compared to the CAHPS® (Commercial) and EES© (Marketplace Exchange) member satisfaction survey results of the member’s success getting their urgent needs meet after hours.

 

As shown, the office level results are barely meeting or are below the expected 90% access to members with urgent symptoms. More telling is members express getting advice as soon as needed less often than the office assessment captures. A sizable number of members sometimes or never reach the doctor’s office for urgent instructions.

After Hours Goals

After Hours

To help both your patients’ and Anthem’s ability to reach your practice, we ask that you verify or update your office information using the online Provider Maintenance Form, and that you also review your after-hours messaging and connectivity for patients’ urgent accessibility. 
  1. Have accessibility 24/7/365. Arrange to have your phone calls forwarded to a service or hospital, or have the appropriate messaging for the caller.
  2. Be sure to turn on a messaging mechanism when you leave the office. 
  3. Be sure you are using the acceptable messaging for compliance with your contract.

Per the provider manual, have your messaging or answering service include appropriate instructions, specifically:
  • Emergency situations:
    • A compliant response for an emergency instructs the caller/patient to hang up and call 911 or go to the emergency room (ER) or live person connects the caller directly to the practitioner.
  • Urgent situations:
    • Compliant responses for urgent needs after hours:
      • Live person, via a service or hospital, advises their practitioner or on-call practitioner is available and connects.
      • Live person or recording directs caller/patient to urgent care, ER or call 911:
        • May also, but not instead of directing, suggest caller/patient contact their healthcare practitioner (via cell phone, pager, text, email, voicemail, etc.) or request a call back for further urgent instructions.
      • Mechanism connects the caller to their practitioner or the practitioner on call.  (Must directly connect.)
  • Non-compliant responses for urgent needs after hours:
    • No provision for after-hours accessibility.
    • Live person or recording only directs the caller/patient to a mechanism for contacting their practitioner (via cell phone, pager, text, email, voicemail, etc.) or to get a call back for urgent questions or instructions.
      These scenarios are non-compliant because there is no direct connection to their practitioner, thus not ensuring a timely callback. This prompt can be used in addition to, but not in place of instructions.

Is your practice compliant?

MULTI-BCBS-CM-012546-22

AdministrativeCommercialDecember 1, 2022

Important information about utilization management

Anthem Blue Cross and Blue Shield (Anthem) utilization management (UM) decisions are based on the appropriateness of care and service needed, as well as the member’s coverage according to their health plan. We do not reward providers or other individuals for issuing denials of coverage, service or care. Nor, do we make decisions about hiring, promoting, or terminating these individuals based on the idea or thought that they will deny benefits. In addition, we do not offer financial incentives for UM decision makers to encourage decisions resulting in under-utilization. Our medical policies are available on Anthem’s website at anthem.com.

 

You can also request a free copy of our UM criteria from our medical management department, and providers may discuss a UM denial decision with a physician reviewer by calling us at the toll-free numbers listed below. UM criteria are also available on the web. Just go to anthem.com, and select Providers > Provider Resources > Policies, Guidelines and Manuals > Select your state > View Medical Policies and Clinical UM Guidelines.

 

We work with providers to answer questions about the utilization management process and the authorization of care. Here’s how the process works:

  • Call us toll free from 8:30 a.m. to 5 p.m., Monday through Friday (except on holidays). More hours may be available in your area. Federal Employee Program (FEP) hours are 8 a.m. to 7 p.m. ET.
  • Our associates will contact you about your UM inquiries during business hours, unless otherwise agreed upon.

 

The following phone lines are for physicians and their staffs. Members should call the customer service number on their health plan ID card.

 

To discuss UM Process and Authorization

To Discuss Peer-to-Peer

UM Denials w/Physician

To Request UM Criteria

TTY/TDD

Business Hours

800-992-5498

866-398-1922

Fax: 888-656-5721

 

Transplant

888-574-7215

Fax: 866-255-2471

National Transplant

844-644-8101

Fax: 888-438-7051

 

Behavioral Health

866-302-1015

 

Autism

Call customer service number on back of member’s ID card.

 

FEP

800-860-2156

Fax: 800-732-8318 (UM)

Fax: 877-606-3807 (ABD)

888-870-9342

 

National

800-821-1453;

866-776-4793

 

Behavioral Health

866-302-1015

 

Adaptive Behavioral Treatment

Call customer service number on back of member’s ID card.

 

FEP

800-860-2156

 

800-992-5498

866-398-1922

Fax: 866-959-1393

 

Behavioral Health

866-302-1015

 

FEP

800-860-2156

Fax: 800-732-8318 (UM)

Fax: 877-606-3807 (ABD)

 

711, or

 

TTY/ASCII:

800-735-2966

 

Voice:

866-735-2460

 

Monday –  Friday (except on holidays)

8:30 a.m. to 5 p.m.

 

More hours may be available in your area.

 

FEP

Monday –  Friday

8 a.m. to 7 p.m. ET

 

For language assistance, members can simply call the Customer Service phone number on the back of their ID card and a representative will be able to assist them.

 

Our utilization management associates identify themselves to all callers by first name, title and our company name when making or returning calls. They can inform you about specific utilization management requirements, operational review procedures, and discuss utilization management decisions with you.

 

MOBCBS-CM-012734-22-CPN12185

AdministrativeCommercialDecember 1, 2022

Members’ rights and responsibilities

The delivery of quality healthcare requires cooperation between patients, their providers, and their healthcare benefit plans. One of the first steps is for patients and providers to understand their rights and responsibilities. Therefore, in line with our commitment to involve the health plan, participating practitioners and members in our system, Anthem Blue Cross and Blue Shield has adopted a Members’ Rights and Responsibilities statement.

 

It can be found on our website under the FAQ question about Laws and Rights that Protect You. To access, go to https://www.anthem.com and select For Providers. From there, select Policies, Guidelines & Manuals under Provider Resources. Select your state, and scroll down to Member Rights and Responsibilities under More Resources. Choose the Read about member rights link. Practitioners may access the FEP member website at www.fepblue.org/memberrights to view the FEPDO Members’ Rights and Responsibilities statement.


MULTI-BCBS-CM-012675-22

AdministrativeCommercialDecember 1, 2022

Member’s assessment of behavioral healthcare after-hours messaging in 2022

We have provided many articles advising of the compliant messaging when our members call your office during an urgent situation after regular business hours.

 

The annual after-hours access studies performed by our vendor, North American Testing Organization* based in California, assesses adequate phone messaging for our members with perceived emergency or urgent situations after office hours. Unfortunately, all Anthem Blue Cross and Blue Shield (Anthem) plans assessed still fall short of the expectation of having a live person or a directive in place for after-hours calls.

 

Well, the members are experiencing this lack of ability to reach instructions and have voiced their opinions in the member experience survey fielded annually for commercial and marketplace exchange via a behavioral health specific survey. An average of 29% of members have a need to contact their behavioral health practitioner after regular hours for urgent care.  They are recalling, in the last 12 months, if they were able to reach the office for instructions, get a consultation they needed or get a timely call back?

 

This chart represents the office level accessibility when contacted by the survey vendor compared to the member satisfaction survey results of the member’s success getting their urgent needs meet after hours. As shown, the office level results are significantly below the expected 90% access to members with urgent symptoms.

 

Ironically, members express getting advice as soon as needed more often than the office assessment captures. Although a number of members sometimes, or never, reached the practitioner’s office for urgent instructions.

BH after hours goals

BH after hours

To help both your patients’ and Anthem’s ability to reach your practice, we ask that you verify or update your office information using the online Provider Maintenance Form and that you also review your after-hours messaging and connectivity for patients’ urgent accessibility.

  1. Have accessibility 24/7/365. Arrange to have your phone calls forwarded to a service or hospital, or have the appropriate messaging for the caller.
  2. Be sure to turn on a messaging mechanism when you leave the office.
  3. Be sure you are using the acceptable messaging for compliance with your contract.

 

Per the Provider Manual, have your messaging or answering service include appropriate instructions, specifically:

 

Emergency situations

Compliant response for an emergency instructs the caller/patient to hang up and call 911 or go to the Emergency Room (ER) or live person connects the caller directly to the practitioner.

 

Emergent/Urgent situations

Compliant responses for urgent needs after hours:

  • Live person or via a service, advises their practitioner or on call practitioner is available and connects.
  • Live person or recording directs or directly connects caller/patient to Urgent Care, 24-hour crisis services, 911 or ER.
    • May also, but not instead of directing, suggest caller/patient may contact their BH care practitioner (via cell phone, pager, text, email, voicemail, etc.) or request a call back for further urgent instructions.
  • Mechanism connects the caller to their practitioner or the practitioner on call. (Must directly connect.)
  • A live person or recording must express if there are prior arrangements with patients for after hour needs, to be compliant.

 

Non-compliant responses for urgent needs after hours:

  • No provision for after hour accessibility.
  • Live person or recording only directs the caller/patient to a mechanism for contacting their practitioner (via cell phone, pager, text, email, voicemail, etc.) or to get a call back for urgent questions or instructions.
    These scenarios are non-compliant because there is no direct connection to their practitioner, thus not ensuring a timely callback. This prompt can be used in addition to, but not in place of instructions.

 

Is your practice compliant?

MULTI-BCBS-CM-012678-22

AdministrativeCommercialDecember 1, 2022

Coordination of care

Coordination of care among providers is a vital aspect of good treatment planning to ensure appropriate diagnosis, treatment, and referral. Anthem Blue Cross and Blue Shield (Anthem) would like to take this opportunity to stress the importance of communicating with your patient’s other healthcare practitioners. This includes PCPs, medical specialists, and behavioral health practitioners.

 

Coordination of care is especially important for patients with high utilization of general medical services, and those referred to a behavioral health specialist by another healthcare practitioner. Anthem urges all its practitioners to obtain the appropriate permission from these patients to coordinate care between behavioral health and other healthcare practitioners at the time treatment begins.

 

We expect all healthcare practitioners to:

  • Discuss with the patient the importance of communicating with other treating practitioners.
  • Obtain a signed release from the patient and file a copy in the medical record.
  • Document in the medical record if the patient refuses to sign a release.
  • Document in the medical record if you request a consultation.
  • If you make a referral, transmit necessary information, and if you are furnishing a referral, report appropriate information back to the referring practitioner.
  • Document evidence of clinical feedback (for example, consultation report) that includes, but is not limited to:
    • Diagnosis.
    • Treatment plan.
    • Referrals.
    • Psychopharmacological medication (as applicable).

 

In an effort to facilitate coordination of care, Anthem has several tools available on our provider website for behavioral health and other medical practitioners including:

  • Coordination of Care Form.
  • Coordination of Care Letter Template - Behavioral Health.
  • Coordination of Care Letter Template - Medical.

 

The following behavioral health forms, brochures, and screening tools for substance use and attention-deficit/hyperactivity disorder (ADHD) are also available on our provider website:

  • Alcohol Use Assessment
  • Antidepressant medication management.
  • Edinburgh Postnatal Depression Scale.
  • Opioid Use Assessment brochure.
  • Substance Brief Intervention/Referral Tool (SBIRT).
  • Vanderbilt ADHD Diagnostic Parent Rating Scale.

MOBCBS-CM-012694-22-CPN12135

AdministrativeCommercialDecember 1, 2022

Case management program

Managing illness can sometimes be a difficult thing to do. Knowing who to contact, what test results mean or how to get needed resources can be a bigger piece of a healthcare puzzle that for some, are frightening and complex issues to handle.

 

Anthem Blue Cross and Blue Shield is available to offer assistance in these difficult moments with our Case Management Program. Our case managers are part of an interdisciplinary team of clinicians and other resource professionals that are there to support members, families, primary care physicians and caregivers. The case management process utilizes experience and expertise of the care coordination team whose goal is to educate and empower our members to increase self-management skills, understand their illness, and learn about care choices in order to access quality, efficient health care.

 

Members or caregivers can refer themselves or family members by calling the number located in the grid below. They will be transferred to a team member based on the immediate need. Physicians can also refer by contacting us telephonically or through electronic means. No issue is too big or too small. We can help with transitions across level of care so that patients and caregivers are better prepared and informed about healthcare decisions and goals.

 

How do you contact us?

 

 

CM Email Address

CM Telephone Number

CM Business Hours

Local

Care.management@anthem.com

 

888-662-0939

866-534-4348 (MO Only)

Monday – Friday

8 a.m. – 7 p.m. CT

FEP

FEP.Care.Coordination@anthem.com

800-711-2225

9 a.m. – 6 p.m. ET

 

MOBCBS-CM-012708-22-CPN12136

AdministrativeCommercialDecember 1, 2022

IngenioRx will become CarelonRx on January 1, 2023

This communication applies to the Commercial and Medicare Advantage programs from Anthem Blue Cross and Blue Shield (Anthem) in Missouri.

 

Our pharmacy benefit management partner, IngenioRx,* will join the Carelon family of companies and change its name to CarelonRx on January 1, 2023.

 

This change will not affect the ways in which CarelonRx will do business with care providers and there will be no impact or changes to the prior authorization process, how claims are processed, or level of support.

 

If your patients are having their medications filled through IngenioRx’s home delivery and specialty pharmacies, please take note of the following information:

  • IngenioRx Home Delivery Pharmacy will become CarelonRx Mail.
  • IngenioRx Specialty Pharmacy will become CarelonRx Specialty Pharmacy.

 

These are name changes only and will not impact patients’ benefits, coverage, or how their medications are filled. Your patients will not need new prescriptions for medicine they currently take.

 

When e-prescribing orders to the mail and specialty pharmacies:

  • Prescribers will need to choose CarelonRx Mail or CarelonRx Specialty Pharmacy, not IngenioRx, if searching by name.
  • If searching by NPI (National Provider Identifier), the NPI will not change.

 

In addition to the mail and specialty pharmacies, your patients can continue to have their prescriptions filled at any in-network retail pharmacy.

 

Keeping you well informed is essential and remains our top priority. We will continue to provide updates prior to January and throughout 2023.

* IngenioRx, Inc. is an independent company providing pharmacy benefit management services on behalf of Anthem Blue Cross and Blue Shield.
MOBCBS-CRCM-013095-22

Policy UpdatesCommercialDecember 1, 2022

Reminder - updated AIM Musculoskeletal program effective January 1, 2023 - site of care reviews

We previously communicated that AIM Specialty Health® (AIM),* a separate company, would expand the AIM Musculoskeletal program to perform medical necessity review of the requested site of service for certain joint and interventional pain procedures beginning September 1, 2022. The expansion was delayed and will now be effective January 1, 2023, for Anthem Blue Cross and Blue Shield’s (Anthem) self-funded (administrative services only) group members, as further outlined below.

 

AIM will continue to manage the AIM Musculoskeletal program and level of care review. The AIM level of care guideline for musculoskeletal surgery and procedures is used for the level of care review. Prior authorization will now also be required for the clinical appropriateness of the site in which the procedure is performed (site of care). AIM will use the following Anthem Clinical Utilization Management Guideline: CG-SURG-52: Site of Care: Hospital-Based Ambulatory Surgical Procedures and Endoscopic Services. The Clinical Criteria to be used for these reviews can be found by going to  https://www.anthem.com/provider/policies/ and selecting the appropriate state. Please note, this does not apply to procedures performed on an emergent basis.

 

A subset of the AIM Musculoskeletal program codes will be reviewed for site of care. A complete list of CPT® codes requiring prior authorization for the AIM Musculoskeletal site of care program is available on the AIM Musculoskeletal microsite. To determine if prior authorization is needed for an Anthem member on or after January 1, 2023, providers can contact the Provider Services phone number on the back of the member’s ID card for benefit information. Providers will be informed whether the AIM Musculoskeletal program applies. AIM will also have a file upload from the health plan of the in-scope membership and will not provide prior authorization for members who are out of scope. If providers use the Interactive Care Reviewer (ICR) tool on Availity* to pre-certify an outpatient musculoskeletal, ICR will produce a message referring the provider to AIM. (Note: ICR cannot accept prior authorization requests for services administered by AIM.)

 

Members included in the new program

This program will be available to a small colume of self-funded (administrative services only) groups that currently participate in the AIM Musculoskeletal program and have added the AIM Musculoskeletal site of care program to their members’ benefit package as of January 1, 2023. Program readiness was evaluated, and it was determined that we are not ready to launch for the fully insured membership. It will also expand to fully insured members currently participating in the AIM Musculoskeletal program at a future date. 

 

Pre-service review requirements

For surgeries that are scheduled to begin on or after January 1, 2023, all providers must contact AIM to obtain prior authorization review. The following groups are excluded: Medicare Advantage, Medicaid, Medicare, Medicare supplement, MA GRS, and the Federal Employee Program® (FEP®). 

 

For services provided on or after January 1, 2023, ordering and servicing providers may begin contacting AIM on January 1 for review. Providers may submit prior authorization requests to AIM in one of several ways:

  • Access AIM’s ProviderPortalSM directly at https://aimspecialtyhealth.com/providerportal. Online access is available 24/7 to process orders in real-time, and this is the fastest and most convenient way to request authorization.
  • Access AIM via Availity at www.availity.com.
  • Call the AIM Contact Center toll-free number at 877-430-2288, Monday through
    Friday, 8 a.m. to 6 p.m. ET.

 

Initiating a request on AIM’s ProviderPortalSM and entering all the requested clinical questions will allow you to receive an immediate determination. If the request is approved, you will receive the order ID, the number of visits, and valid time frame. The AIM Musculoskeletal program microsite on the AIM provider website helps you learn more, and you can access helpful information and tools such as order entry checklists.

 

AIM Musculoskeletal training webinars                                                                    

Anthem invites you to take advantage of a free informational webinar that will introduce you to the program and the robust capabilities of the AIM ProviderPortalSM.  Go to the AIM Musculoskeletal microsite to register for an upcoming webinar. If you have previously registered for other services managed by AIM, there is no need to register again.

 

We value your participation in our network and look forward to working with you to help improve the health of our members.

* AIM Specialty Health is an independent company providing some utilization review services on behalf of Anthem Blue Cross and Blue Shield. Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield.


MULTI-BCBS-CM-014243-22

Medical Policy & Clinical GuidelinesCommercialDecember 1, 2022

AIM Specialty Health Cardiology Clinical Appropriateness Guidelines CPT Code List update

This communication applies to the Commercial and Medicare Advantage programs from Anthem Blue Cross and Blue Shield (Anthem).

 

Effective for dates of service on and after February 1, 2023, the following code updates will apply to the AIM Specialty Health®* diagnostic coronary angiography and the percutaneous coronary intervention Clinical Appropriateness Guidelines.

 

Diagnostic coronary angiography:

CPT® code

Description

92973

Percutaneous transluminal coronary thrombectomy mechanical (list separately in addition to code for primary procedure)

92974

Transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy (list separately in addition to code for primary procedure)

92978

Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vessel (list separately in addition to code for primary procedure)

92979

Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; each additional vessel (list separately in addition to code for primary procedure)

 

Percutaneous coronary intervention:

CPT code

Description

92975

Thrombolysis, coronary; by intracoronary infusion, including selective coronary angiography

C1714

Catheter, transluminal atherectomy, directional

C1724

Catheter, transluminal atherectomy, rotational

C1725

Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)

C1753

Catheter, intravascular ultrasound

C1760

Closure device, vascular (implantable/insertable)

C1761

Catheter, transluminal intravascular lithotripsy, coronary

C1769

Guide wire

C1874

Stent, coated/covered, with delivery system

C1875

Stent, coated/covered, without delivery system

C1876

Stent, non-coated/non-covered, with delivery system

C1877

Stent, non-coated/non-covered, without delivery system

C1885

Catheter, transluminal angioplasty, laser

C1887

Catheter, guiding (may include infusion/perfusion capability)

 

As a reminder, ordering and servicing providers may submit prior authorization requests to AIM in one of several ways:

  • Access AIM’s ProviderPortalSM directly at www.providerportal.com.
  • Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
  • Access AIM via Availity* Essentials at availity.com.

 

Detailed prior authorization requirements are available online at availity.com through the Precertification Lookup Tool.

 

If you have questions related to guidelines, contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you may access and download a copy of the current and upcoming guidelines here.

*AIM Specialty Health is an independent company providing some utilization review services on behalf of Anthem Blue Cross and Blue Shield.

*Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield.
MULTI-BCBS-CRCM-008167-22-CPN7092

Medical Policy & Clinical GuidelinesCommercialDecember 1, 2022

AIM Specialty Health Genetic Testing Clinical Appropriateness Guidelines CPT Code List update

Effective for dates of service on and after April 1, 2023, the following codes will require prior authorization through AIM Specialty Health.

 

CPT code

Description

81175

ASXL1 (additional sex combs like 1, transcriptional re.g.ulator) (e.g., myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia), gene analysis; full gene sequence

81176

ASXL1 (additional sex combs like 1, transcriptional re.g.ulator) (e.g., myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia), gene analysis; targeted sequence analysis (e.g., exon 12)

81206

BCR/ABL1 (t(9;22)) (e.g., chronic myelogenous leukemia) translocation analysis; major breakpoint, qualitative or quantitative

81207

BCR/ABL1 (t(9;22)) (e.g., chronic myelogenous leukemia) translocation analysis; minor breakpoint, qualitative or quantitative

81208

BCR/ABL1 (t(9;22)) (e.g., chronic myelogenous leukemia) translocation analysis; other breakpoint, qualitative or quantitative

81218

CEBPA (CCAAT/enhancer binding protein [C/EBP], alpha) (e.g., acute myeloid leukemia), gene analysis, full gene sequence

81233

BTK (Bruton's tyrosine kinase) (e.g., chronic lymphocytic leukemia) gene analysis, common variants (e.g., C481S, C481R, C481F)

81236

EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) (e.g., myelodysplastic syndrome, myeloproliferative neoplasms) gene analysis, full gene sequence

81237

EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) (e.g., diffuse large B-cell lymphoma) gene analysis, common variant(s) (e.g., codon 646)

81273

KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (e.g., mastocytosis), gene analysis, D816 variant(s)

81310

NPM1 (nucleophosmin) (e.g., acute myeloid leukemia) gene analysis, exon 12 variants

81315

PML/RARalpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (e.g., promyelocytic leukemia) translocation analysis; common breakpoints (e.g., intron 3 and intron 6), qualitative or quantitative

81316

PML/RARalpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (e.g., promyelocytic leukemia) translocation analysis; single breakpoint (e.g., intron 3, intron 6 or exon 6), qualitative or quantitative

81320

PLCG2 (phospholipase C gamma 2) (e.g., chronic lymphocytic leukemia) gene analysis, common variants (e.g., R665W, S707F, L845F)

81334

RUNX1 (runt related transcription factor 1) (e.g., acute myeloid leukemia, familial platelet disorder with associated myeloid malignancy), gene analysis, targeted sequence analysis (e.g., exons 3-8)

81347

SF3B1 (splicing factor [3b] subunit B1) (e.g., myelodysplastic syndrome/acute myeloid leukemia) gene analysis, common variants (e.g., A672T, E622D, L833F, R625C, R625L)

81348

SRSF2 (serine and arginine-rich splicing factor 2) (e.g., myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variants (e.g., P95H, P95L)

81357

U2AF1 (U2 small nuclear RNA auxiliary factor 1) (e.g., myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variants (e.g., S34F, S34Y, Q157R, Q157P)

81360

ZRSR2 (zinc finger CCCH-type, RNA binding motif and serine/arginine-rich 2) (e.g., myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variant(s) (e.g., E65fs, E122fs, R448fs)

0016U

Oncology (hematolymphoid neoplasia), RNA, BCR/ABL1 major and minor breakpoint fusion transcripts, quantitative PCR amplification, blood or bone marrow, report of fusion not detected or detected with quantitation

0040U

BCR/ABL1 (t(9;22)) (e.g., chronic myelogenous leukemia) translocation analysis, major breakpoint, quantitative

0049U

NPM1 (nucleophosmin) (e.g., acute myeloid leukemia) gene analysis, quantitative

0101U

Hereditary colon cancer disorders (e.g., Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatous polyposis), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with MRNA analytics to resolve variants of unknown significance when indicated (15 genes [sequencing and deletion/duplication], EPCAM and GREM1 [deletion/duplication only])

0102U

Hereditary breast cancer-related disorders (e.g., hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with MRNA analytics to resolve variants of unknown significance when indicated (17 genes [sequencing and deletion/duplication])

0103U

Hereditary ovarian cancer (e.g., hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with MRNA analytics to resolve variants of unknown significance when indicated (24 genes [sequencing and deletion/duplication], EPCAM [deletion/duplication only])

0306U

Gastric emptying, serial collection of 7 timed breath specimens, non-radioisotope carbon-13 (13C) spirulina substrate, analysis of each specimen by gas isotope ratio mass spectrometry, reported as rate of 13CO2 excretion

0307U

Clostridium difficile toxin(s) antigen detection by immunoassay technique, stool, qualitative, multiple-step method

0314U

Oncology (cutaneous melanoma), mRNA gene expression profiling by RT-PCR of 35 genes (32 content and 3 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a cate.g.orical result (ie, benign, intermediate, malignant)

0315U

Oncology (cutaneous squamous cell carcinoma), mRNA gene expression profiling by RT-PCR of 40 genes (34 content and 6 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a cate.g.orical risk result (ie, Class 1, Class 2A, Class 2B)

0318U

Pediatrics (congenital epigenetic disorders), whole genome methylation analysis by microarray for 50 or more genes, blood

0323U

Infectious agent detection by nucleic acid (DNA and RNA), central nervous system pathogen, metagenomic next-generation sequencing, cerebrospinal fluid (CSF), identification of pathogenic bacteria, viruses, parasites, or fungi

0326U

Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 83 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden

0329U

Oncology (neoplasia), exome and transcriptome sequence analysis for sequence variants, gene copy number amplifications and deletions, gene rearrangements, microsatellite instability and tumor mutational burden utilizing DNA and RNA from tumor with DNA from normal blood or saliva for subtraction, report of clinically significant mutation(s) with therapy associations

0331U

Oncology (hematolymphoid neoplasia), optical genome mapping for copy number alterations and gene rearrangements utilizing DNA from blood or bone marrow, report of clinically significant alterations

S3852

DNA analysis for APOE epsilon 4 allele for susceptibility to Alzheimer's disease

 

As a reminder, ordering and servicing providers may submit prior authorization requests to AIM in one of several ways:

  • Access AIM’s ProviderPortalSM directly at providerportal.com
    • Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
  • You can also access AIM Specialty Health in some markets through www.Availity.com.
    • Log onto www.Availity.com and select Authorizations and Referrals. Scroll down and select AIM Specialty Health. You will then be diverted to the AIM Specialty Health provider portal

 

For questions related to guidelines, please contact AIM via email at aim.guidelines@aimspecialtyhealth.com . Additionally, you may access and download a copy of the current and upcoming guidelines http://www.aimspecialtyhealth.com/ClinicalGuidelines.html.


* AIM Specialty Health is an independent company providing some utilization review services on behalf of Anthem Blue Cross and Blue Shield.
* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield.

MULTI-BCBS-CM-012086-22

Medical Policy & Clinical GuidelinesCommercialDecember 1, 2022

Medical Policies and Clinical Guidelines updates - December 2022

The following Medical Polices, and Clinical Guidelines for Anthem Blue Cross and Blue Shield (Anthem) were reviewed on August 11, 2022.

 

To view Medical Policies and Clinical Guidelines, go to www.anthem.com > select Providers > select your state > under Provider Resources, select Policies, Guidelines & Manuals.

 

To help determine if prior authorization is needed for Anthem members, go to www.anthem.com > select Providers > select your state > under Claims, select Prior Authorization. You can also call the prior authorization phone number on the back of the member’s ID card.

 

To view Medical Policies and Clinical Guidelines applicable to members enrolled in the Blue Cross and Blue Shield Service Benefit Plan (commonly referred to as the Federal Employee Program® [FEP®]), please visit www.fepblue.org > Policies & Guidelines.

 

Below are the new medical policies and/or clinical guidelines that have been approved.

* Denotes prior authorization required

 

Policy/guideline

Information

Effective date

*MED.00140 Gene Therapy for Beta Thalassemia

  • Outlines the MN and INV&NMN criteria for a one-time infusion of betibeglogene autotemcel for individuals with beta thalassemia
  • No specific code for Zynteglo, listed NOC codes C9399, J3490, J3590 for the product, and ICD-10-PCS codes for transfusion of genetically modified stem cells to be reviewed for MN criteria; effective 10/01/2022 there will be specific ICD-10-PCS codes XW133B8, XW143B8 for transfusion of betibeglogene autotemcel

03/01/2023

DME.00049 External Upper Limb Stimulation for the Treatment of Tremors

  • Wrist-worn external upper limb tremor stimulator is considered INV&NMN for all indications, including but not limited to the treatment of essential tremor of the hands
  • Existing HCPCS codes K1018, K1019 will be considered INV&NMN 

03/01/2023

*DME.00050 Remote Devices for Intermittent Monitoring of Intraocular Pressure

  • The use of remote devices for intermittent monitoring of IOP is considered INV&NMN for all indications
  • No specific code for this type of device, considered INV&NMN; listed E1399 NOC

03/01/2023

LAB.00049 Artificial Intelligence-Based Software for Prostate Cancer Detection

  • Use of artificial intelligence-based software for prostate cancer detection is considered INV&NMN for all indications
  • No specific code for this product, considered INV&NMN; listed 88399 NOC

03/01/2023

MED.00141 High-volume Colonic Irrigation

  • High-volume colonic irrigation is considered INV&NMN for all indications
  • Existing CPT Category 3 code 0736T (effective 07/1/2022) considered INV&NMN

03/01/2023

TRANS.00040 Hand Transplantation

  • Hand transplantation is considered INV&NMN
  • No specific code CPT code, listed 26989 NOC; specific ICD-10-PCS proc codes 0XYJ0Z0, 0XYJ0Z1, 0XYK0Z0, 0XYK0Z1; considered INV&NMN

03/01/2023

 

Below are the current clinical guidelines and/or medical policies we reviewed, and updates were approved.

* Denotes prior authorization required

 

Policy/guideline

Information

Effective date

*CG-DME-31 Powered Wheeled Mobility Devices

  • Added HCPCS code E0986 for push-rim device, will be reviewed for MN criteria (was listed in CG-DME-34)

03/01/2023


MULTI-BCBS-CM-012522-22-CPN11473

Reimbursement PoliciesCommercialDecember 1, 2022

Reimbursement policy update: Multiple Surgery - Facility

In the October 2021, edition of the Provider News, Anthem Blue Cross and Blue Shield (Anthem) announced a new commercial policy titled Multiple Bilateral Surgery Processing - Facility effective for dates of service on or after January 1, 2022. The policy indicated that Modifier 50 must be appended to facility claims when a bilateral procedure is performed. At this time, we have decided to remove this requirement for dates of service on or after January 1, 2022. Bilateral services should be billed as they were billed prior to January 1, 2022. The policy will be updated to remove the following:

 

  • Modifier 50 must be appended to facility claims when a bilateral procedure is performed.
  • When a surgical procedure code description contains the terminology bilateral or unilateral or bilateral or the code is considered inherently bilateral, modifiers LT, RT, or 50 should not be appended.

 

In addition, the policy title will be renamed to Multiple Surgery - Facility.

 

For specific policy details, visit the reimbursement policy page at anthem.com provider website.

MOBCBS-CM-012539-22

Reimbursement PoliciesCommercialDecember 1, 2022

Reimbursement policy update: Bundled Services and Supplies - Professional

Beginning with dates of service on or after March 1, 2023, Anthem Blue Cross and Blue Shield (Anthem) will update the Bundled Services and Supplies Policy - Professional to include two new CPT codes, 87913 and K1034, as not eligible for separate reimbursement.  Specifically, Section 1 of the policy will be revised as follows to add these 2 new CPT codes:

 

The following codes are not eligible for reimbursement when they are reported with another service or reported as a stand-alone service:

  • 87913 - Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identification in targeted region(s).
  • K1034 - Provision of COVID-19 test, nonprescription self-administered and self-collected use, FDA approved, authorized, or cleared, one test count.

 

For specific policy details, visit the reimbursement policy page on anthem.com.

 

MOBCBS-CM-012665-22

Reimbursement PoliciesCommercialDecember 1, 2022

Reimbursement policy update: Treatment Rooms with Office Evaluation and Management Services - Facility

Beginning with dates of service on or after March 1, 2023, Anthem Blue Cross and Blue Shield (Anthem) will update the Related Coding section of the Treatment Rooms with Office Evaluation and Management Services – Facility policy to include HCPCS code G0463. The code description for G0463 is hospital outpatient clinic visits or assessment and management of a patient. G0463 is not eligible for reimbursement when reported with revenue code 760, 761, or 769.

 

For specific policy details, visit the reimbursement policy page on the anthem.com provider website.

MOBCBS-CM-012723-22

PharmacyCommercialDecember 1, 2022

Pharmacy information available on the provider website

Visit the Drug Lists page on anthem.com for more information on:
  • Copayment/coinsurance requirements and their applicable drug classes.
  • Drug Lists and changes.
  • Prior Authorization Criteria.
  • Procedures for generic substitution.
  • Therapeutic interchange.
  • Step therapy or other management methods subject to prescribing decisions.
  • Any other requirements, restrictions, or limitations that apply to using certain drugs.

 

The Commercial and Exchange Drug Lists are posted to the website quarterly on the first day of the month in January, April, July, and October.

 

To locate the Exchange Select Formulary and pharmacy information, scroll down to Select Drug Lists. This drug list is also reviewed and updated regularly as needed.

 

Federal Employee Program (FEP) pharmacy updates and other pharmacy related information may be accessed at www.fepblue.org > Pharmacy Benefits.


MULTI-BCBS-CM-012589-22-CPN12133

PharmacyCommercialDecember 1, 2022

Specialty pharmacy updates - December 2022

Specialty pharmacy updates for Anthem Blue Cross and Blue Shield (Anthem) are listed below.

 

Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by Anthem’s Medical Specialty Drug Review team. Review of specialty pharmacy drugs for oncology use is managed by AIM Specialty Health® (AIM), a separate company.

 

Inclusion of a National Drug Code (NDC) code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code.

 

Step therapy updates:


Clinical Criteria ING-CC-0182 currently has a step therapy preferring Ferrlecit®, Infed®, and Venofer®.

 

Effective for dates of service on and after March 1, 2023, the status of Infed in current criteria documents will be changing in our existing specialty pharmacy medical step therapy review process. This update is to notify that Infed will change to non-preferred.

 

Also, effective for dates of service on or after December 1, 2022, Feraheme® (ferumoxytol) will change to preferred for both brand and generic.

 

Access our Clinical Criteria to view the complete information for these step therapy updates.

 

Clinical Criteria

Status

Drug

HCPCS or CPT® code(s)

ING-CC-0182

Nonpreferred

Infed (iron dextran)

J1750

ING-CC-0182

Nonpreferred

Injectafer® (ferric carboxymaltose)

J1439

ING-CC-0182

Nonpreferred

Monoferric® (ferric derisomaltose)

J1437

ING-CC-0182

Preferred

Feraheme (ferumoxytol)

Q0138

ING-CC-0182

Preferred

Ferrlecit (sodium ferric gluconate/sucrose complex)

J2916

ING-CC-0182

Preferred

Venofer® (iron sucrose)

J1756

 

* AIM Specialty Health is an independent company providing some utilization review services on behalf of Anthem Blue Cross and Blue Shield.

MULTI-BCBS-CM-012643-22-CPN12421

State & FederalMedicare AdvantageDecember 1, 2022

Keep up with Medicare News - December 2022

State & FederalMedicare AdvantageDecember 1, 2022

2023 Medicare Advantage service area and benefit updates

An overview of notable 2023 benefit changes and service area updates are now available here. Please continue to check https://www.anthem.com/provider/medicare-advantage for the latest Medicare Advantage information.

MOBCBS-CR-012232-22-CPN10053

State & FederalMedicare AdvantageDecember 1, 2022

Personal home helper benefit ending

Navigating the complexities and nuances associated with the COVID-19 pandemic requires frequent review of benefits and their impacts to our members’ social drivers of health. In recent evaluations, significant challenges have been identified by many agencies supporting our personal home helper benefit.

 

These nationwide impacts have led to many members unable to use the benefit to its fullest capacity. Therefore, effective January 1, 2023, the personal home helper benefit will no longer be offered within any of Anthem Blue Cross and Blue Shield’s (Anthem’s) Medicare individual plans. Members have been notified via their Annual Notice of Change. Improving the life of our members is Anthem’s focus and, while this change is difficult, Anthem will make best efforts to identify other resources for members or benefits to enhance their quality of life.

 

Please direct any member concerns or questions to the member services number on the back of their card.

MULTI-BCBS-CR-011952-22-CPN11945